Centrus has designed and operated the world's most advanced gas centrifuge enrichment technology (American Centrifuge) and is pioneering production of High-Assay, Low-Enriched Uranium while restoring America's uranium enrichment capabilities at scale. As the only NRC-licensed HALEU producer, the company holds exclusive market positioning in specialized uranium enrichment.
Cyborg Score Rationale
The company achieved 5.6% net income growth in 2025, expanded its LEU backlog to $2.3 billion, and nearly tripled cash reserves to $1.95 billion. Strategic government contracts and dominant market position offset valuation risks and execution uncertainties.
Top Insights
Department of Energy selected Centrus for a $900 million HALEU order in January, with agreements covering South Korea, Oklo, TerraPower, and X-energy
Exclusive capability in HALEU enrichment positions Centrus for outsized market share, pricing power, and superior margin expansion as Russian supply diminishes
U.S. Department of Energy announced $2.7 billion funding injection for nuclear energy sector expansion at Centrus' Ohio enrichment facility
Company's stock has surged 83% over the past 12 months with strong bottom-line performance
Named Competitors
Uranium enrichment services — Multi-commodity uranium and rare earth producer
Uranium enrichment services — Uranium exploration and development company
LEU/uranium products — Russian nuclear fuel company (contract expires 2026)
Recent Developments
(February 2026) JP Morgan reaffirms Hold rating; multiple analyst price target adjustments reflect valuation consolidation
(January 2026) Department of Energy selects Centrus for $900 million HALEU order